Optimizing the CD34 + cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Optimizing the CD34 + cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation

Published:2009-01 Issue:9 Volume:50 Page:1434-1441
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Mehta Jayesh,Mehta Jayesh,Frankfurt Olga,Altman Jessica,Evens Andrew,Tallman Martin,Gordon Leo,Williams Stephanie,Winter Jane,Krishnamurthy Jairam,Duffey Sara,Singh Veerpal,Meagher Richard,Grinblatt David,Kaminer Lynne,Singhal Seema

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190903085944

Reference25 articles.

1. DEATH BY GRAFT-VERSUS-HOST DISEASE ASSOCIATED WITH HLA MISMATCH, HIGH RECIPIENT AGE, LOW MARROW CELL DOSE, AND SPLENECTOMY

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High CD34‐positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft‐versus‐host disease or mortality;Transfusion;2024-05

2. Hematopoietic Cell Collection;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

3. Higher graft cell dose does not influence development of acute or chronic GVHD in haploidentical transplantation using PTCy;Blood Advances;2023-08-11

4. Association between CD34+ and CD3+ T-cells in allogeneic grafts and acute graft-versus-host disease in children undergoing allogeneic hematopoietic stem cell transplantation: A single-center study;Transplant Immunology;2023-04

5. Effect of CD34+ Cell Dose on the Outcomes of Allogeneic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide;Transplantation and Cellular Therapy;2023-03